Targeted Disruption of the JAK2/STAT3 Pathway in Combination with Systemic Administration of Paclitaxel Inhibits the Priming of Ovarian Cancer Stem Cells Leading to a Reduced Tumor Burden
Author:
Publisher
Frontiers Media SA
Subject
Cancer Research,Oncology
Reference46 articles.
1. Challenges for chemotherapy in ovarian cancer;Ozols;Ann Oncol,2006
2. Back to the future: targeting molecular changes for platinum resistance reversal;Gabra;Gynecol Oncol,2010
3. Meeting the challenge of ascites in ovarian cancer: new avenues for therapy and research;Kipps;Nat Rev Cancer,2013
4. Synergistic interaction between cisplatin and taxol in human ovarian carcinoma cells in vitro;Jekunen;Br J Cancer,1994
5. Overcoming challenges of ovarian cancer stem cells: novel therapeutic approaches;Aguilar-Gallardo;Stem Cell Rev,2012
Cited by 64 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. The role of stromal cells in epithelial–mesenchymal plasticity and its therapeutic potential;Discover Oncology;2024-01-20
2. Potential drug repurposing of ruxolitinib to inhibit the JAK/STAT pathway for the treatment of patients with epithelial ovarian cancer;Journal of Obstetrics and Gynaecology Research;2023-08-10
3. Multi-Omics Identification of Genetic Alterations in Head and Neck Squamous Cell Carcinoma and Therapeutic Efficacy of HNC018 as a Novel Multi-Target Agent for c-MET/STAT3/AKT Signaling Axis;International Journal of Molecular Sciences;2023-06-16
4. Study on Modification of Paclitaxel and Its Antitumor Preparation;Russian Journal of Bioorganic Chemistry;2023-02-21
5. Plasticity of Cancer Stem Cell;Cancer Stem Cells: Basic Concept and Therapeutic Implications;2023
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3